Schizophrenia has of late become a global concern owing to its debilitating effects on a victim. The fatality of this brain disease has therefore attracted the attention of scientists, as illustrated by the development of the science of neuroimaging. In particular, neuroimaging provides immediate as well as vivid brain images that are then used in discovering key neural bases that subject a person to psychiatric symptoms. Neuroimaging has contributed to the understanding and treatment of schizophrenic disease mechanisms immensely (Winton-Brown & Kapur, 2009).
On this background, this research paper will critically explore how neuroimaging is applied in the clinical practice of diagnosing and treating schizophrenia. The paper will serve as an abstract for further research on the relevance of neuroimaging in schizophrenia treatment.
The science of nueroimaging employs 3D technology to encode anatomical variation patterns, thereby detecting functional alteration patterns in the brains of specific groups. According to Winton-Brown and Kapur (2009), nueroimaging enables the location of the brain areas that are pertinent to schizophrenia, such as the thalamus and the hippocampus. Further, there are certain groups of people that are at a high risk of contracting the disease. From image 3 below, neuroimaging actually facilitates the identification of such groups. The progression rate of schizophrenia can also be monitored through nueroimaging, as exhibited by image 2. Nueroimaging processes like photon emission generate images that reflect how specific brain molecules are distributed (Winton-Brown & Kapur, 2009).
Images generated by neurochemical processes reveal that schizophrenia is a gradual process whose development can be monitored and subsequently stopped. Neurochemical imaging is an excellent technique to use in diagnosing schizophrenia in terms of the likely course along with outcome, disease mechanisms, and response to treatment doses. Consequently, clinicians should embrace neuroimaging besides other diagnostic and treatment procedures in seeking a long-term solution to schizophrenia.
Rapid Response:
Re: Renaming schizophrenia
Schizophrenia has of late become a global concern owing to its debilitating effects on a victim. The fatality of this brain disease has therefore attracted the attention of scientists, as illustrated by the development of the science of neuroimaging. In particular, neuroimaging provides immediate as well as vivid brain images that are then used in discovering key neural bases that subject a person to psychiatric symptoms. Neuroimaging has contributed to the understanding and treatment of schizophrenic disease mechanisms immensely (Winton-Brown & Kapur, 2009).
On this background, this research paper will critically explore how neuroimaging is applied in the clinical practice of diagnosing and treating schizophrenia. The paper will serve as an abstract for further research on the relevance of neuroimaging in schizophrenia treatment.
The science of nueroimaging employs 3D technology to encode anatomical variation patterns, thereby detecting functional alteration patterns in the brains of specific groups. According to Winton-Brown and Kapur (2009), nueroimaging enables the location of the brain areas that are pertinent to schizophrenia, such as the thalamus and the hippocampus. Further, there are certain groups of people that are at a high risk of contracting the disease. From image 3 below, neuroimaging actually facilitates the identification of such groups. The progression rate of schizophrenia can also be monitored through nueroimaging, as exhibited by image 2. Nueroimaging processes like photon emission generate images that reflect how specific brain molecules are distributed (Winton-Brown & Kapur, 2009).
Images generated by neurochemical processes reveal that schizophrenia is a gradual process whose development can be monitored and subsequently stopped. Neurochemical imaging is an excellent technique to use in diagnosing schizophrenia in terms of the likely course along with outcome, disease mechanisms, and response to treatment doses. Consequently, clinicians should embrace neuroimaging besides other diagnostic and treatment procedures in seeking a long-term solution to schizophrenia.
Reference
Allen Istitute for Brain Science. (2010, June 9th). Allen Human Brains Atlas: Mapping Genes in Action. Retrieved September 18th, 2012, from Allen Istitute for Brain Science: http://www.google.co.ke/url?sa=t&rct=j&q=sample%20digital%20atlases%20-%...
Winton-Brown, T. T. and Kapur, S. (2009). Nueroimaging of Schizophrenia: What it Reveals about the Disease and What it Tells us about a Patient. Retrieved September 18th, 2012, from "http://www.annals.edu.sg/pdf/38VolNo5May2009/V38N5p433.pdf"
Competing interests: No competing interests